Avadel Pharmaceuticals (AVDL) Treasury Shares: 2009-2022
Historic Treasury Shares for Avadel Pharmaceuticals (AVDL) over the last 3 years, with Jun 2020 value amounting to $50.0 million.
- Avadel Pharmaceuticals' Treasury Shares changed negligibly% to $50.0 million in Q2 2020 from the same period last year, while for Jun 2020 it was $50.0 million, marking a year-over-year negligible change of negligibly%. This contributed to the annual value of $50.0 million for FY2019, which is negligibly% changed negligibly from last year.
- Per Avadel Pharmaceuticals' latest filing, its Treasury Shares stood at $2.2 million for Q3 2022, which was up 304.67% from $535,000 recorded in Q4 2021.
- In the past 5 years, Avadel Pharmaceuticals' Treasury Shares ranged from a high of $5.4 million in Q3 2018 and a low of $347,000 during Q4 2020.
- Its 3-year average for Treasury Shares is $2.8 million, with a median of $2.2 million in 2022.
- Data for Avadel Pharmaceuticals' Treasury Shares shows a peak YoY soared of 248.71% (in 2018) over the last 5 years.
- Over the past 4 years, Avadel Pharmaceuticals' Treasury Shares (Quarterly) stood at $22.4 million in 2017, then skyrocketed by 123.59% to $50.0 million in 2018, then remained steady at $50.0 million in 2019, then remained steady at $50.0 million in 2020.
- Its last three reported values are $50.0 million in Q2 2020, $50.0 million for Q1 2020, and $50.0 million during Q4 2019.